Citi Reiterates Buy Rating on PhaseBio (PHAS); Most Undervalued in Coverage Dec 18, 2019 07:39AM
PhaseBio Pharmaceuticals Inc. (PHAS) PT Lowered to $25 at Citi Sep 3, 2019 03:29AM
Citi Reiterates Buy Rating on PhaseBio Pharmaceuticals Inc. (PHAS) May 24, 2019 06:30AM
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 16, 2019 04:01PM
PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 16, 2019 04:01PM


Apr 12, 2019 06:11AM PhaseBio Pharmaceuticals Inc. (PHAS) Prices 3.6M Shares at $12
Apr 11, 2019 09:19PM PhaseBio Announces Pricing of Public Offering of Common Stock
Apr 11, 2019 09:19PM PhaseBio Announces Pricing of Public Offering of Common Stock
Apr 10, 2019 09:25AM Pre-Open Stock Movers 04/10: (BRSS) (TPX) (LEVI) Higher; (PTE) (PHAS) (ABC) Lower (more...)
Apr 9, 2019 04:46PM PhaseBio Pharmaceuticals Inc. (PHAS) Confirms 3M Share Offering of Common Stock
Apr 9, 2019 04:45PM PhaseBio Announces Proposed Public Offering of Common Stock
Apr 9, 2019 04:45PM PhaseBio Announces Proposed Public Offering of Common Stock
Nov 12, 2018 07:02AM Citi Starts PhaseBio Pharmaceuticals Inc. (PHAS) at Buy
Oct 18, 2018 10:24AM PhaseBio Pharmaceuticals (PHAS) IPO Opens Flat
Oct 8, 2018 07:00AM PhaseBio Launches Roadshow for Initial Public Offering